You are here

Omidria

A Seattle biotech offloads lead eye drug in deal valued at $1B+ as it refocuses on emerging pipeline

Endpoints

Thu, 12/2/21 - 11:00 am

cataract surgery

post-operative pain

Rayner Surgical

Omeros Prevails in Patent Dispute With Sandoz

CP Wire

Thu, 07/26/18 - 11:24 am

Omeros Prevails in Patent Dispute With Sandoz

Thu, 07/26/18 - 09:12 am

patent lawsuits

Omeros notches $13 million in sales of first drug

Bizjournals.com

Mon, 03/7/16 - 09:55 pm

post-surgical pain

FDA approves Omeros eye drug

Yahoo/Reuters

Mon, 06/2/14 - 10:49 am